A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination with Insulin Aspart, in Adults with Type 1 Diabetes

16498ONWARDS11-NN1436-8182OpenA 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination with Insulin Aspart, in Adults with Type 1 Diabetes NCT07076199IndustrialAdultTreatmentOtherPark, JeanMedStar Health and GUMC; Medstar Montgomery Medical CenterMedStar Medical & Surgical Research Network7043Maria HurtadoMaria HurtadoMaria.E.Hurtado@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>